These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6243991)

  • 1. Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899).
    Labia R; Lelievre V; Peduzzi J
    Biochim Biophys Acta; 1980 Feb; 611(2):351-7. PubMed ID: 6243991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kinetics of beta-lactamase inhibition by clavulanic acid].
    Labia R; Peduzzi J
    Biochim Biophys Acta; 1978 Oct; 526(2):572-9. PubMed ID: 363163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillanic acid sulfone: nature of irreversible inactivation of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5833-9. PubMed ID: 6098299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T; Tsukamoto K
    J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of TEM-1 beta-lactamase by 6-acetylmethylenepenicillanic acid.
    Arisawa M; Then R
    Biochem J; 1983 Mar; 209(3):609-15. PubMed ID: 6307259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5839-46. PubMed ID: 6098300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.
    Lin S; Thomas M; Shlaes DM; Rudin SD; Knox JR; Anderson V; Bonomo RA
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):395-400. PubMed ID: 9735103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-beta-(Trifluoromethane sulfonyl)-amido-penicillanic acid sulfone: a potent inhibitor for beta-lactamases.
    Mezes PS; Clarke AJ; Dmitrienko GI; Viswanatha T
    FEBS Lett; 1982 Jul; 143(2):265-7. PubMed ID: 6288463
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of beta-lactamase inhibitors with various beta-lactamases.
    Cullmann W
    Chemotherapy; 1990; 36(3):200-8. PubMed ID: 2159863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA; Rudin SA; Shlaes DM
    FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX; McElrath MJ; Neu HC
    Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. I. Inhibition of chromosomally and R-factor-mediated beta-lactamases.
    Arisawa M; Then RL
    J Antibiot (Tokyo); 1982 Nov; 35(11):1578-83. PubMed ID: 6298167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-beta-bromopenicillanic acid, a potent beta-lactamase inhibitor.
    Pratt RF; Loosemore MJ
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4145-9. PubMed ID: 212736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME; Fu KP; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CO2 and pH on inhibition of TEM-1 and other beta-lactamases by penicillanic acid sulfones.
    Livermore DM; Corkill JE
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1870-6. PubMed ID: 1329633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam.
    Yamaguchi A; Hirata T; Sawai T
    Antimicrob Agents Chemother; 1983 Jul; 24(1):23-30. PubMed ID: 6312873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillanic acid sulfone: interaction with RTEM beta-lactamase from Escherichia coli at different pH values.
    Kemal C; Knowles JR
    Biochemistry; 1981 Jun; 20(13):3688-95. PubMed ID: 6268141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
    Thomson CJ; Amyes SG
    J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of beta-lactamase of Streptomyces cacaoi. II. CP-45,899, izumenolide and cephamycins.
    Mantoku A; Ogawara H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1347-50. PubMed ID: 6273376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.